Please use this identifier to cite or link to this item:
http://adhlui.com.ui.edu.ng/jspui/handle/123456789/3053
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | ADELUSI, B | - |
dc.contributor.author | OSUNKOYA, B O | - |
dc.contributor.author | FABIYI, A | - |
dc.date.accessioned | 2024-10-09T10:04:57Z | - |
dc.date.available | 2024-10-09T10:04:57Z | - |
dc.date.issued | 1976 | - |
dc.identifier.citation | Afr. J. Med. med. Sci. (1976)5, 297-301 | en_US |
dc.identifier.issn | 1116-4077 | - |
dc.identifier.uri | http://adhlui.com.ui.edu.ng/jspui/handle/123456789/3053 | - |
dc.description | ARTICLE | en_US |
dc.description.abstract | Various studies have associated Herpes Type-2 (HT-2) virus with carcinoma of the cervix, especially the squamous cell type. In the present study, prevalence of HT-2 virus antibodies was found to be significantly higher in patients with squamous cell carcinoma of the cervix than in cases with squamous cell carcinoma of sites other than the cervix, and other pelvic and extra pelvic malignancies (/'< 0 001). It was concluded that no association could be found between Herpes Type-2 virus and malignancies of sites other than the cervix | en_US |
dc.description.sponsorship | COLLEGE OF MEDICINE,UNIVERSITY OF IBADAN | en_US |
dc.language.iso | en | en_US |
dc.publisher | COLLEGE OF MEDICINE | en_US |
dc.subject | squamous | en_US |
dc.subject | cervix | en_US |
dc.subject | herpes | en_US |
dc.subject | extrapelvic | en_US |
dc.title | Herpes type-2 virus antibody status in groups of patients with neoplasm in Ibadan | en_US |
dc.type | Article | en_US |
Appears in Collections: | African Journal of Medicine and Medical Sciences |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Adelusi et al_Herpes_1976.pdf | ARTICLE | 5.78 MB | Adobe PDF | View/Open |
Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.